V3DA:XETRA:XETRA-Vanguard ESG Developed Europe All Cap UCITS ETF EUR Accumulation (EUR)

ETF | Others |

Last Closing

USD 6.065

Change

-0.03 (-0.46)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict
Created with Highstock 5.0.6

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
V3DA:XETRA
Relative Returns (From:    To: 2025-01-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.50 (+0.96%)

USD 445.28B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.19 (+1.14%)

USD 191.96B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.30 (+1.06%)

USD 177.46B
PRAJ:XETRA Amundi Index Solutions - Amund..

N/A

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.07 (+0.26%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.92 (+2.01%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

+2.90 (+2.03%)

USD 98.84B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.56 (+1.08%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

N/A

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+9.12 (+1.51%)

USD 80.38B

ETFs Containing V3DA:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.50% 65% D 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.50% 65% D 61% D-
Trailing 12 Months  
Capital Gain 10.39% 52% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.39% 50% F 53% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.79% 55% F 56% F
Dividend Return 7.79% 54% F 54% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.10% 70% C- 76% C+
Risk Adjusted Return 96.22% 85% B 87% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike